IT’S TIME FOR A NEW DIRECTION IN TREATING AND REVERSING NEURODEGENERATIVE DISEASES:

WE ARE DEVELOPING DRUGS FOR ALZHEIMER’S AND PARKINSON’S DISEASE, INCLUDING THE ORPHAN INDICATION DEMENTIA AND ALZHEIMER’S IN DOWN SYNDROME

Annovis Bio, Inc.’s novel approach to addressing chronic and acute neurodegeneration offers new hope in the fight against the largest unmet need of an aging population